Výsledky vyhledávání

Akademický článek

Arthroscopic synovectomy versus intra-articular injection of corticosteroids for the management of refractory psoriatic or rheumatoid arthritis of the wrist: study protocol for a randomized controlled trial (ARCTIC trial)

Autor: P. N. d’Ailly, C. Deugd, N. W. L. Schep, T. M. Kuijper, M. R. Kok, A. Willemze, J. H. Coert, P. H. P. de Jong, W. K. Lam-Tse, A. H. M. van der Helm-van Mil, I. Tchetverikov, A. E. A. M. Weel-Koenders, R. J. Bisoendial

Publikováno v: Trials, Vol 24, Iss 1, Pp 1-13 (2023)

Abstract Background Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are inflammatory diseases that often affect the wrist and, when affected, can lead to impaired wrist function and progressive joint destruction if inadequately treated. Stand

Externí odkaz: https://doaj.org/article/d2de371d0bea4928906af3b3fa37eb12

Zobrazit plný text záznamu

Akademický článek

Sex-specific differences and how to handle them in early psoriatic arthritis

Autor: E. Passia, M. Vis, L. C. Coates, A. Soni, I. Tchetverikov, A. H. Gerards, M. R. Kok, P. A. J. M. Vos, L. Korswagen, F. Fodili, Y. P. M. Goekoop-Ruiterman, J. van der Kaap, M. van Oosterhout, J. J. Luime

Publikováno v: Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-10 (2022)

Abstract Objectives The prevalence of psoriatic arthritis (PsA) is the same in men and women; however, the latter experience a higher burden of disease and are affected more frequently by polyarthritis. Here, we performed an early PsA cohort analysis

Externí odkaz: https://doaj.org/article/a09f6c08e8f44ee3bf6bb95f22fabbe6

Zobrazit plný text záznamu

Akademický článek

Incorporating geography into a new generalized theoretical and statistical framework addressing the modifiable areal unit problem

Autor: M. Tuson, M. Yap, M. R. Kok, K. Murray, B. Turlach, D. Whyatt

Publikováno v: International Journal of Health Geographics, Vol 18, Iss 1, Pp 1-15 (2019)

Abstract Background All analyses of spatially aggregated data are vulnerable to the modifiable areal unit problem (MAUP), which describes the sensitivity of analytical results to the arbitrary choice of spatial aggregation unit at which data are meas

Externí odkaz: https://doaj.org/article/1b30e99d5fbe4d0697820bf7bda1a331

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Absence of ultrasound inflammation in patients presenting with arthralgia rules out the development of arthritis

Autor: Myrthe van der Ven, M. van der Veer-Meerkerk, D. F. Ten Cate, N. Rasappu, M. R. Kok, D. Csakvari, J. M. W. Hazes, A. H. Gerards, J. J. Luime

Publikováno v: Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-7 (2017)

Abstract Background To decrease the burden of disease of rheumatoid arthritis (RA), patients at risk for RA need to be identified as early as possible, preferably when no clinically apparent synovitis can be detected. Up to now, it has been fairly di

Externí odkaz: https://doaj.org/article/79413bc0590240cea1e26c284833e835

Zobrazit plný text záznamu

OP0263 FAVORABLE BALANCE OF BENEFIT AND HARM OF LONG-TERM, LOW-DOSE PREDNISOLONE ADDED TO STANDARD TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS AGED 65+: THE PRAGMATIC, MULTICENTER, PLACEBO- CONTROLLED GLORIA TRIAL

Autor: M. Boers, L. Hartman, D. Opris-Belinski, R. Bos, M. R. Kok, J. A. P. da Silva, E. N. Griep, R. Klaasen, C. Allaart, P. Baudoin, H. Raterman, Z. Szekanecz, F. Buttgereit, P. Masaryk, T. Klausch, S. Paolino, A. M. Schilder, W. Lems, M. Cutolo

Publikováno v: Annals of the Rheumatic Diseases. 81:174-175

BackgroundLow-dose glucocorticoid (GC) therapy is widely used in RA but the true balance of benefit and harm is still unknown.ObjectivesWe studied the effects of prednisolone (5 mg/day, 2 years) in RA patients aged 65+, requiring adjustment of antirh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a87b79cd2db9a157f8cd24ebfaefbf5a
https://doi.org/10.1136/annrheumdis-2022-eular.698

Zobrazit plný text záznamu

POS1054 PAIN AND DEPRESSION ARE ASSOCIATED WITH NON-RESPONSE TO METHOTREXATE IN PATIENTS WITH PSORIATIC ARTHRITIS

Autor: F. R. Kasiem, L. Tucker, M. Vis, J. Luime, I. Tchetverikov, K. Wervers, J. Hazes, L. Coates, M. R. Kok

Publikováno v: Annals of the Rheumatic Diseases. 81:847.1-847

BackgroundPsoriatic arthritis (PsA) is a heterogeneous, immune-mediated inflammatory arthritis. Methotrexate (MTX) is the first-line treatment in PsA patients, despite diverse clinical phenotypes and highly varied responses(1). As yet, it is not poss

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b8376b000bd69b4f320abf70fa49b1a
https://doi.org/10.1136/annrheumdis-2022-eular.2762

Zobrazit plný text záznamu

POS1084 IMPACT OF PSORIASIS REMAINS IMPORTANT IN PSORIATIC ARTHRITIS PATIENTS WITH LOW MUSCULOSKELETAL DISEASE ACTIVITY

Autor: F. R. Kasiem, M. R. Kok, J. Luime, I. Tchetverikov, K. Wervers, J. Hazes, M. Vis

Publikováno v: Annals of the Rheumatic Diseases. 81:868.2-869

BackgroundPsoriatic arthritis (PsA) is a complex, chronic auto-immune disease that affects health-related Quality of Life (HRQoL). Earlier research showed that general HRQoL in PsA patients is mainly affected by musculoskeletal pain.1 However, psoria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dae68f9583b340c69dd9add20f9c54b9
https://doi.org/10.1136/annrheumdis-2022-eular.2639

Zobrazit plný text záznamu

OP0028 EARLY ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY IN PSORIATIC ARTHRITIS IS ASSOCIATED WITH LONG-TERM IMPROVEMENTS IN QUALITY OF LIFE

Autor: S. Snoeck Henkemans, P. De Jong, J. Luime, M. R. Kok, I. Tchetverikov, A. Van der Helm-van Mil, M. Vis

Publikováno v: Annals of the Rheumatic Diseases. 81:21.1-21

BackgroundMinimal disease activity (MDA) is a treatment target in psoriatic arthritis (PsA) that takes both clinical manifestations (joints, skin and enthesis) and the patient perspective into account (1). In a previous study we have shown that achie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e7d5f363bad62cd11e35d64a85ca28b0
https://doi.org/10.1136/annrheumdis-2022-eular.2090

Zobrazit plný text záznamu

POS0652 LONG-TERM EFFECTIVENESS OF ULTRA-LOW DOSES OF RITUXIMAB IN RHEUMATOID ARTHRITIS

Autor: N. Den Broeder, L. M. Verhoef, Y. A. De Man, M. R. Kok, R. M. Thurlings, W. Van der Weele, B. Van den Bemt, F. Van den Hoogen, A. Van der Maas, A. Den Broeder

Publikováno v: Annals of the Rheumatic Diseases. 81:597.2-598

BackgroundThe optimal rituximab (RTX) dose for the treatment of rheumatoid arthritis remains unclear. RTX treatment of 1000mg per 6 months and 2000mg per 6 months were shown to be similarly efficacious (1). The REDO trial showed comparable the 6-mont

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::401b9dddab9c5e268da221004f73fc6e
https://doi.org/10.1136/annrheumdis-2022-eular.2903

Zobrazit plný text záznamu

OP0070 INTERVENTION WITH METHOTREXATE IN ARTHRALGIA AT RISK FOR RHEUMATOID ARTHRITIS TO REDUCE THE DEVELOPMENT OF PERSISTENT ARTHRITIS AND ITS DISEASE BURDEN (TREAT EARLIER): A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL

Autor: D. Krijbolder, M. Verstappen, B. van Dijk, Y. Dakkak, L. Burgers, A. Boer, Y. Jung Park, M. De Witt, K. Visser, M. R. Kok, E. Molenaar, P. de Jong, S. Böhringer, T. Huizinga, C. Allaart, E. Niemantsverdriet, A. van der Helm-van Mil

Publikováno v: Annals of the Rheumatic Diseases. 81:48.1-49

BackgroundRheumatoid arthritis (RA) is the most common autoimmune disease, and requires long-term treatment to suppress inflammation. Currently, methotrexate is initiated as first-line treatment when arthritis becomes clinically apparent with joint s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e39becce4a7a501cbc78ec076cbf0fe4
https://doi.org/10.1136/annrheumdis-2022-eular.264

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání